A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.

In a study designed to compare response rates of patients with stage III epithelial ovarian carcinoma to ifosfamide and carboplatin, 152 patients were randomised to receive either sequential therapy with three cycles of ifosfamide followed by three cycles of carboplatin, or to six cycles of single a...

Descripción completa

Detalles Bibliográficos
Autores principales: Perren, T. J., Wiltshaw, E., Harper, P., Slevin, M., Stein, R., Tan, S., Gore, M., Fryatt, I. J., Blake, P. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968655/
https://www.ncbi.nlm.nih.gov/pubmed/8260372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968655/
https://www.ncbi.nlm.nih.gov/pubmed/8260372

Ejemplares similares